Pettipher R
Oxagen Ltd, 91 Milton Park, Abingdon, Oxon, UK.
Br J Pharmacol. 2008 Mar;153 Suppl 1(Suppl 1):S191-9. doi: 10.1038/sj.bjp.0707488. Epub 2007 Oct 29.
Prostaglandin D(2) (PGD(2)) is produced by mast cells, Th2 lymphocytes and dendritic cells and has been detected in high concentrations at sites of allergic inflammation. PGD(2) exerts its inflammatory effects through high affinity interactions with the G protein coupled receptors DP(1) and chemoattractant-homologous receptor expressed on Th2 cells (CRTH2, also known as DP(2)). DP(1) and CRTH2 act in concert to promote a number of biological effects associated with the development and maintenance of the allergic response. During the process of allergen sensitization, DP(1) activation may enhance polarization of Th0 cells to Th2 cells by inhibiting production of interleukin 12 by dendritic cells. Upon exposure to allergen in sensitized individuals, activation of DP(1) may contribute to the long lasting blood flow changes in the target organ. CRTH2 is expressed by Th2 lymphocytes, eosinophils and basophils and may mediate the recruitment of these cell types during the late phase allergic response. The role played by CRTH2 in promoting the production of Th2 cytokines and IgE make antagonism of this receptor a particularly attractive approach to the treatment of chronic allergic disease.
前列腺素D2(PGD2)由肥大细胞、Th2淋巴细胞和树突状细胞产生,在过敏性炎症部位已检测到其高浓度存在。PGD2通过与G蛋白偶联受体DP1和Th2细胞上表达的趋化因子同源受体(CRTH2,也称为DP2)进行高亲和力相互作用来发挥其炎症作用。DP1和CRTH2协同作用,促进与过敏反应的发生和维持相关的多种生物学效应。在过敏原致敏过程中,DP1激活可能通过抑制树突状细胞产生白细胞介素12来增强Th0细胞向Th2细胞的极化。在致敏个体接触过敏原后,DP1激活可能导致靶器官持久的血流变化。CRTH2由Th2淋巴细胞、嗜酸性粒细胞和嗜碱性粒细胞表达,可能在迟发性过敏反应期间介导这些细胞类型的募集。CRTH2在促进Th2细胞因子和IgE产生中所起的作用使得拮抗该受体成为治疗慢性过敏性疾病特别有吸引力的方法。